CA2483327A1 - Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations - Google Patents

Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations Download PDF

Info

Publication number
CA2483327A1
CA2483327A1 CA002483327A CA2483327A CA2483327A1 CA 2483327 A1 CA2483327 A1 CA 2483327A1 CA 002483327 A CA002483327 A CA 002483327A CA 2483327 A CA2483327 A CA 2483327A CA 2483327 A1 CA2483327 A1 CA 2483327A1
Authority
CA
Canada
Prior art keywords
seq
strain
sequence
htlv
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002483327A
Other languages
English (en)
French (fr)
Inventor
Felix Jinhyun Kim
Nicolas Gabriel Albert Manel
Marc Khamous Michel Sitbon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Montpellier
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2483327A1 publication Critical patent/CA2483327A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
CA002483327A 2002-04-22 2003-04-22 Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations Abandoned CA2483327A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0205001A FR2838740A1 (fr) 2002-04-22 2002-04-22 Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations
FR02/05001 2002-04-22
PCT/FR2003/001274 WO2003088979A2 (fr) 2002-04-22 2003-04-22 Oligonucleotide issus des sequences codant pour la composante de surface de proteines d'enveloppe des virus des lymphomes / leucemies t chez les primates (ptlv) et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2483327A1 true CA2483327A1 (fr) 2003-10-30

Family

ID=28686243

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002483327A Abandoned CA2483327A1 (fr) 2002-04-22 2003-04-22 Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations

Country Status (10)

Country Link
US (2) US7507529B2 (enExample)
EP (1) EP1497467B1 (enExample)
JP (1) JP4541712B2 (enExample)
AT (1) ATE440150T1 (enExample)
AU (1) AU2003246850A1 (enExample)
CA (1) CA2483327A1 (enExample)
DE (1) DE60328880D1 (enExample)
ES (1) ES2328130T3 (enExample)
FR (1) FR2838740A1 (enExample)
WO (1) WO2003088979A2 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20040121313A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
FR2838740A1 (fr) * 2002-04-22 2003-10-24 Centre Nat Rech Scient Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations
JP2006516193A (ja) 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド ヒトおよび動物における病原体の迅速な同定方法
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8394945B2 (en) 2003-09-11 2013-03-12 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
ES2641832T3 (es) 2004-05-24 2017-11-14 Ibis Biosciences, Inc. Espectrometría de masas con filtración de iones selectiva por establecimiento de umbrales digitales
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US20060205040A1 (en) 2005-03-03 2006-09-14 Rangarajan Sampath Compositions for use in identification of adventitious viruses
WO2007014045A2 (en) 2005-07-21 2007-02-01 Isis Pharmaceuticals, Inc. Methods for rapid identification and quantitation of nucleic acid variants
US8088582B2 (en) 2006-04-06 2012-01-03 Ibis Biosciences, Inc. Compositions for the use in identification of fungi
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
US8871471B2 (en) 2007-02-23 2014-10-28 Ibis Biosciences, Inc. Methods for rapid forensic DNA analysis
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
US8148163B2 (en) 2008-09-16 2012-04-03 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
WO2010033599A2 (en) 2008-09-16 2010-03-25 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
US9719083B2 (en) 2009-03-08 2017-08-01 Ibis Biosciences, Inc. Bioagent detection methods
WO2010114842A1 (en) 2009-03-30 2010-10-07 Ibis Biosciences, Inc. Bioagent detection systems, devices, and methods
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
US9416409B2 (en) 2009-07-31 2016-08-16 Ibis Biosciences, Inc. Capture primers and capture sequence linked solid supports for molecular diagnostic tests
EP3098325A1 (en) 2009-08-06 2016-11-30 Ibis Biosciences, Inc. Non-mass determined base compositions for nucleic acid detection
US9890408B2 (en) 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
WO2011115840A2 (en) 2010-03-14 2011-09-22 Ibis Biosciences, Inc. Parasite detection via endosymbiont detection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0384566A3 (en) * 1989-01-27 1991-11-13 The Wistar Institute Amplification of htlv-1 sequences from multiple sclerosis patients
WO2000046403A2 (en) 1999-02-03 2000-08-10 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OFHEALT H AND HUMAN SERVICES Methods and reagents for molecular detection of hiv-1 groups m, n and o
FR2838740A1 (fr) * 2002-04-22 2003-10-24 Centre Nat Rech Scient Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations

Also Published As

Publication number Publication date
AU2003246850A8 (en) 2003-11-03
US7947452B2 (en) 2011-05-24
US20050287521A1 (en) 2005-12-29
EP1497467A2 (fr) 2005-01-19
WO2003088979A3 (fr) 2004-02-19
ATE440150T1 (de) 2009-09-15
AU2003246850A1 (en) 2003-11-03
JP4541712B2 (ja) 2010-09-08
DE60328880D1 (de) 2009-10-01
US20090186338A1 (en) 2009-07-23
US7507529B2 (en) 2009-03-24
EP1497467B1 (fr) 2009-08-19
ES2328130T3 (es) 2009-11-10
FR2838740A1 (fr) 2003-10-24
WO2003088979A2 (fr) 2003-10-30
JP2005538696A (ja) 2005-12-22

Similar Documents

Publication Publication Date Title
CA2483327A1 (fr) Oligonucleotides issus des sequences codant pour la composante de surface des proteines d'enveloppe des ptlv et leurs utilisations
AU745235B2 (en) Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
EP0404625B1 (fr) Séquences oligonucléotidiques pour l'amplification du génome des rétrovirus du type HIV-2 et SIV, et leurs applications au diagnostic in-vitro des infections dûes à ces virus
FR2780069A1 (fr) Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
JP2025166082A (ja) 分子ガイドシステムペプチド及びその使用
JP2022115974A (ja) 化学療法誘発性末梢性ニューロパシーおよび難聴を処置または予防するためのbcl-wポリペプチドおよび模倣物
EP3384934B1 (en) Targeted shell for use in drug delivery system utilizing carbosilane dendrimer
CA2298834C (fr) Sequences retroviraux endogenes, associees a des maladies auto-immunes et/ou a des perturbations de la grossesse
US11666562B2 (en) Ilaprazole for inhibiting the release of enveloped viruses from cells
EP0577458A1 (fr) Séquences nucléotidiques et peptidiques issues de la souche Wo du VIF et applications desdites séquences au diagnostic et à la prévention de l'immunodéficience féline
CN115943152A (zh) 使用基于肽核酸的药剂治疗SARS-CoV-2感染的方法和组合物
CA2443290C (fr) Souche neurovirulente du virus west-nile et ses applications
JP4927546B2 (ja) ヘプタペプチドパターン及び細胞透過ドメインを含む相互作用ポリペプチド
WO2012076822A1 (fr) Peptides et medicament antiviral
EP1259606B1 (fr) Compositions utilisables pour reguler l'activite de la parkine
EP0828832A2 (fr) $g(D)P62, SES VARIANTS, SEQUENCES D'ACIDES NUCLEIQUES LES CODANT, ET LEURS UTILISATIONS EN THERAPIE GENIQUE ANTI-CANCEREUSE
CA2632708A1 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
Peralta Branched Peptides Targeting HIV-1 RRE RNA and Structure-Activity Relationship Studies of Spinster Homolog 2 Inhibitors
EP0465602A1 (fr) PROCEDE DE DETECTION ET/OU D'IDENTIFICATION DES INFECTIONS A $i(LYSSAVIRUS), CLONAGE ET EXPRESSION DE GENES CODANT POUR DES PEPTIDES ET/OU DES FRAGMENTS DE PEPTIDES DU $i(LYSSAVIRUS) MOKOLA, VACCIN CONTRE LE VIRUS MOKOLA ET/OU L'ENSEMBLE DES $i(LYSSAVIRUS) AINSI QUE PROCEDE D'OBTENTION DUDIT VACCIN
FR3127756A1 (fr) Polypeptides neutralisants et leurs applications
FR2692279A1 (fr) Séquences nucléotidiques issues de la souche WO du vif et leurs fragments, applications desdites séquences à l'expression de peptides immunogènes et au diagnostic de l'immunodéficience féline.
FR2815358A1 (fr) Polypeptides inhibiteurs de l'ires du virus de l'hepatite c et procede de criblage desdits polypeptides
Thuzar et al. Maintenance of Virulence Markers in the UPM 93273 IBDV Isolate After 48 Passages in SPF Embryonated Chicken Eggs
Moccia Synthesis of Novel L-diamino acid-based cationic peptides for biomedical applications
FR2725214A1 (fr) Nouveaux composes utilisables pour la preparation d'agents anti-infectieux

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20141203